- Current report filing (8-K)
January 07 2010 - 6:03AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest event Reported):
January 7, 2010 (January 1, 2010)
|
|
|
|
CHINA BIOLOGIC PRODUCTS, INC.
|
(Exact name of registrant as
specified in its charter)
|
|
|
|
Delaware
|
|
|
001-34566
|
|
|
75-2308816
|
|
(State or other jurisdiction of
incorporation or organization)
|
(Commission File No.)
|
(IRS Employer ID No.)
|
|
|
|
|
|
|
No. 14 East Hushan Road,
|
|
|
Tai'an City, Shandong
|
|
|
People's Republic of China
|
|
271000
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
|
|
|
|
(011)-86-538 -620-2306
|
|
Registrant's telephone number, including area code
|
|
|
(Former name or former address, if
changed since last report)
|
Check the appropriate box below if
the Form 8-K filing is intended to simultaneously satisfy the filing obligation
of the registrant under any of the following provisions (
see
General
Instruction A.2. below):
£
Written communications pursuant to Rule
425 under the Securities Act (17 CFR 230.425)
£
Soliciting material pursuant to Rule
14a-12 under the Exchange Act (17 CFR 240.14a-12)
£
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR 240.14d-2(b))
£
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act
(17 CFR 240.13e-4(c))
Item 4.01.
Changes in Registrants Certifying Accountant.
China Biologic Products, Inc. (the
"Company") was notified that, effective January 1, 2010, certain partners of
Moore Stephens Wurth Frazer and Torbet, LLP ("MSWFT") and Frost, PLLC ("Frost")
formed Frazer Frost, LLP ("Frazer Frost"), a new partnership. Pursuant to the
terms of a combination agreement by and among MSWFT, Frazer Frost and Frost (the
"Combination Agreement"), each of MSWFT and Frost contributed all
of their assets and certain of their liabilities to Frazer Frost, resulting in
Frazer Frost assuming MSWFTs engagement letter with the Company and becoming
the Companys new independent accounting firm. As of the date of this Current
Report, Frazer Frost is not registered with the Public Company Accounting and
Oversight Board (PCAOB), however such registration is in process.
The audit reports of MSWFT on the
financial statements of the Company as of and for the years ended December 31,
2008 and December 31, 2007 did not contain an adverse opinion or a disclaimer of
opinion, and were not qualified or modified as to uncertainty, audit scope or
accounting principles.
During the Companys most two recent
fiscal years ended December 31, 2008 and 2007 and through January 1, 2010, the
Company did not consult with Frazer Frost on (i) the application of accounting
principles to a specified transaction, either completed or proposed, or the type
of audit opinion that may be rendered on the Companys financial statements, and
Frazer Frost did not provide either a written report or oral advice to the
Company that was an important factor considered by the Company in reaching a
decision as to any accounting, auditing, or financial reporting issue; or (ii)
the subject of any disagreement, as defined in Item 304 (a)(1)(iv) of Regulation
S-K and the related instructions, or a reportable event within the meaning set
forth in Item 304(a)(1)(v) of Regulation S-K.
In connection with the audits of the
Companys financial statements for the fiscal years ended December 31, 2008 and
2007 and through the date of this Current Report, there were: (i) no
disagreements between the Company and MSWFT on any matters of accounting
principles or practices, financial statement disclosure, or auditing scope or
procedures, which disagreements, if not resolved to the satisfaction of MSWFT,
would have caused MSWFT to make reference to the subject matter of the
disagreement in their reports on the Companys financial statements for such
years, and (ii) no reportable events within the meaning set forth in Item
304(a)(1)(v) of Regulation S-K.
The Company has provided MSWFT a copy
of the disclosures in this Form 8-K and has requested that MSWFT furnish it with
a letter addressed to the Securities and Exchange Commission stating whether or
not MSWFT agrees with the Companys statements in this Item 4.01(a). A copy of
the letter dated January 7, 2010, furnished by MSWFT in response to that request
is filed as Exhibit 16.1 to this Form 8-K.
Item 9.01.
Financial Statements and Exhibits.
(c) Exhibits
SIGNATURES
Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly authorized.
Date: January 7, 2010
|
CHINA BIOLOGIC
PRODUCTS, INC.
|
|
|
|
|
|
|
|
By:
|
/s/ Chao Ming Zhao
|
|
|
Chao
Ming Zhao
|
|
|
Chief Executive Officer
|
|
|
|
China Bioligic Products (NASDAQ:CBPO)
Historical Stock Chart
From Jun 2024 to Jul 2024
China Bioligic Products (NASDAQ:CBPO)
Historical Stock Chart
From Jul 2023 to Jul 2024